Health Care & Life Sciences » Pharmaceuticals | Chunghwa Chemical Synthesis & Biotech Co. Ltd.

Chunghwa Chemical Synthesis & Biotech Co. Ltd. | Income Statement

Fiscal year is January-December. All values TWD Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
1,043
947
1,162
1,199
1,168
1,019
Cost of Goods Sold (COGS) incl. D&A
686
671
779
808
788
698
Gross Income
357
276
384
391
380
321
SG&A Expense
258
253
284
292
302
290
EBIT
99
23
100
98
78
31
Unusual Expense
-
1
7
-
-
10
Non Operating Income/Expense
27
29
252
1
40
228
Interest Expense
12
14
8
7
8
11
Pretax Income
114
38
336
93
110
239
Income Tax
17
23
28
33
24
6
Consolidated Net Income
97
15
308
60
86
234
Net Income
97
15
308
60
86
234
Net Income After Extraordinaries
97
15
308
60
86
234
Net Income Available to Common
97
15
308
60
86
234
EPS (Basic)
1.25
0.19
3.98
0.78
1.11
3.02
Basic Shares Outstanding
78
78
78
78
78
78
EPS (Diluted)
1.24
0.19
3.96
0.77
1.10
2.99
Diluted Shares Outstanding
78
78
78
78
78
78
EBITDA
182
120
202
213
212
166
Non-Operating Interest Income
-
1
-
-
1
-
Minority Interest Expense
-
-
-
-
-
-

About Chunghwa Chemical Synthesis & Biotech Co.

View Profile
Address
No. 1 Dongxing Street
New Taipei TP 238 50
Taiwan
Employees -
Website http://www.ccsb.com.tw
Updated 07/08/2019
Chunghwa Chemical Synthesis & Biotech Co., Ltd. engages in the manufacture of active pharmaceutical ingredient (API). Its products include pain management for skeletal muscle pain and migraine, immunosuppressant for reducing immune activity after organ transplant, antifungal such as fluconazole,caspofungin and micafungin, oncology that act against cancers, and other APIs for lowering cholesterol and anti diabetic drugs. The company was founded on May 19, 1964 and is headquartered in New Taipei, Taiwan.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.